Newsletter Archive

  1. 10.17.24 -- Resources For Trouble-Free Validation 10/17/2024

    10/17/24 Advancing RNA Newsletter

  2. 10.16.24 -- Shifting Scales: Considerations For Small-Scale mRNA Production 10/16/2024
    10/16/24 Advancing RNA Newsletter
  3. 10.09.24 -- Tips For Addressing Vaccine Demand – No Matter Your Therapeutic Background 10/9/2024

    10/09/24 Advancing RNA Newsletter

  4. 10.09.24 -- One Unspoken Issue With FDA's Platform Designation 10/9/2024
    10/09/24 Advancing RNA Newsletter
  5. 10.02.24 -- FDA's Platform Guidance Raises Questions For mRNA Makers 10/2/2024
    10/02/24 Advancing RNA Newsletter
  6. 09.26.24 -- Industrializing mRNA Therapeutics 9/26/2024

    09/26/24 Advancing RNA Newsletter

  7. 09.25.24 -- Pivoting To RNA With Circio's Dr. Erik Digman Wiklund 9/25/2024
    09/25/24 Advancing RNA Newsletter
  8. 09.23.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions 9/23/2024
    09/23/24 Advancing RNA Newsletter
  9. 09.18.24 -- Two "Spicy" Takeaways On The FDA's Platform Designation Guidance 9/18/2024
    09/18/24 Advancing RNA Newsletter
  10. 09.17.24 -- Outsourcing Strategies To Maximize RNA-LNP Success 9/17/2024

    09/17/24 Advancing RNA Newsletter